|
|
Drugs for Penile Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 156)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Leuprolide | approved, investigational | Phase 4 | 299 | 53714-56-0 | 3911, 657181 | (D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone 5-oxoPro-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-ProNHC2H5 dihydrate 5-oxoprolylhistidyltryptophylseryltyrosylleucylleucyl-n5-(diaminomethylidene)ornithyl-n-ethylprolinamide AC1L1GZK AC1L9B44 AC1Q5OPO AR-1G9354 C07612 CID3911 CID441410 D00989 D08113 Enantone Enantone (TN) I04-0109 L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide L001094 | L002030 Leuprolide Leuprolide acetate Leuprolide acetate (USAN) Leuprorelin Leuprorelin (INN) Leuprorelin acetate (JAN) Leuprorelina Leuproreline Leuprorelinum Lupron (TN) N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide NSC377526 NSC746847 PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5 PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet acetic acid leuprolide | |
| | 2 | | Tadalafil | approved, investigational | Phase 4, Phase 3 | 155 | 171596-29-5 | 110635 | (6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione (6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione 171596-29-5 1xoz 6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione AC1L380B ADCIRCA Acdirca Adcirca C429886 CHEBI:41488 CHEMBL779 CID110635 CPD000466321 Cialis Cialis (TN) Cialis, GF 196960, IC 351, ICOS 351, Tadalafil D02008 DB00820 FT-0080116 GF 196960 GF-196960 | HMS2051N17 HSDB 7303 IC 351 IC-351 ICOS 351 Ic351 KS-1117 LS-186558 LS-187015 LS-187770 Lilly brand of tadalafil MLS000759426 MLS001165782 MLS001195644 MLS001424132 MolPort-002-885-864 S1512_Selleck SAM001246586 SMR000466321 Tadalafil Tadalafil (JAN/USAN/INN) Tadalafil [USAN] Tadanafil UNII-742SXX0ICT ZINC03993855 | |
| | 3 | | Udenafil | approved, investigational | Phase 4 | 34 | 268203-93-6 | 6918523 | 3-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl]-4-propoxybenzenesulfonamide 5-(2-Propyloxy-5-(1-methyl-2-pyrollidinylethylamidosulfonyl)phenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidine-7-one AC1OCFJA CID6918523 | DA 8159 DA-8159 DB06267 I14-12963 Udenafil Zydena |
| | 4 | | Vaccines | | Phase 4, Phase 3, Phase 1, Phase 2 | 6611 | | | | 5 | | Vasodilator Agents | | Phase 4, Phase 3, Early Phase 1 | 3543 | | | | 6 | | Phosphodiesterase 5 Inhibitors | | Phase 4, Phase 3, Phase 2, Early Phase 1 | 589 | | | | 7 | | Fertility Agents | | Phase 4 | 505 | | | | 8 | | Phosphodiesterase Inhibitors | | Phase 4, Phase 3, Phase 2, Early Phase 1 | 1289 | | | | 9 | | Antineoplastic Agents, Hormonal | | Phase 4, Phase 3, Early Phase 1 | 5592 | | | | 10 | | Pharmaceutical Solutions | | Phase 4, Phase 1, Phase 2 | 8192 | | | | 11 | | Coagulants | | Phase 4 | 1500 | | | | 12 | | Hemostatics | | Phase 4 | 1443 | | | | 13 | | Testosterone | approved, investigational | Phase 3, Early Phase 1 | 563 | 58-22-0 | 6013 | (+)-testosterone (+-)-8-iso-testosterone (+-)-retrotestosterone (+-)-testosterone (17b)-17-hydroxy-androst-4-en-3-one (17beta)-17-Hydroxyandrost-4-en-3-one (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 13-Iso-testosterone 17-Hydroxy-(17-beta)-androst-4-en-3-one 17-Hydroxy-(17beta)-androst-4-en-3-one 17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one 17-Hydroxy-D4-androsten-3-one 17-Hydroxy-androst-4-en-3-one 17-beta-Hydroxy-delta(sup 4)-androsten-3-one 17-beta-Hydroxyandrost-4-en-3-one 17?-Hydroxy-4-androsten-3-one 17a-Hydroxy-(13a)-androst-4-en-3-one 17a-Hydroxy-13a-androst-4-en-3-one 17a-Hydroxy-14b-androst-4-en-3-one 17a-Hydroxy-androst-4-en-3-one 17b-Hydroxy-(10a)-androst-4-en-3-one 17b-Hydroxy-(13a)-androst-4-en-3-one 17b-Hydroxy-(8a)-androst-4-en-3-one 17b-Hydroxy-(8a,10a)-androst-4-en-3-one 17b-Hydroxy-(9b)-androst-4-en-3-one 17b-Hydroxy-(9b,10a)-androst-4-en-3-one 17b-Hydroxy-13a-androst-4-en-3-one 17b-Hydroxy-8a-androst-4-en-3-one 17b-Hydroxy-D4-androsten-3-one 17b-Hydroxy-androst-4-en-3-on 17b-Hydroxy-androst-4-en-3-one 17b-Hydroxyandrost-4-en-3-one 17b-Hydroxyandrost-4-ene-3-one 17b-Testosterone 17b-hydroxy-4-androsten-3-one 17beta-Hydroxy-3-oxo-4-androstene 17beta-Hydroxy-4-androsten-3-one 17beta-Hydroxy-delta(sup4)-androsten-3-one 17beta-Hydroxyandrost-4-en-3-one 17beta-Hydroxyandrost-4-ene-3-one 17beta-hydroxy-4-androsten-3-one 4-Androsten-17?-ol-3-one 4-Androsten-17beta-ol-3-one 4-Androsten-3-one-17b-ol 4-androsten-17β-ol-3-one 4-androstene-17beta-ol-3-one 46923_FLUKA 46923_RIEDEL 58-22-0 7-beta-Hydroxyandrost-4-en-3-one 8-Iso-testosterone 9b,10a-Testosterone 9b-Testosterone AA 2500 AC-14899 AC1L1LM0 Andriol Andro Andro 100 Andro L.A. 200 AndroGel Androderm Androderm (TN) Androgel Androgel (TN) Android 10 Android 25 Android 5 Androlin Andronaq Andronate 100 Andronate 200 Andropatch Andropository 200 Androsorb Androst-4-en-17b-ol-3-one Androst-4-en-17beta-ol-3-one Androst-4-ene-17b-ol-3-one Andrusol Andryl 200 B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E BIDD:ER0555 BIM-0061761.0001 Beta Testosterone Bio-0678 Bio-T-Gel C00535 CCRIS 574 CDB 111C CHEBI:17347 CHEMBL386630 CID6013 CMC_13449 COL 1621 CP 601B CPD000058344 Cristerona T Cristerone T D00075 D4-Androsten-17b-ol-3-one DB00624 Dea No. 4000 Delatest Delatestryl Depo-Testadiol Depo-Testosterone Depo-Testosterone Cypionate Depotest EINECS 200-370-5 Epitestosteron Everone 200 Geno-Cristaux Gremy Geno-cristaux Gremy Geno-cristaux gremy HMS2052N11 HSDB 3398 Halotensin Homosteron Homosterone | Intrinsa LMST02020002 LS-148813 LibiGel Libigel Lumitestosteron MLS000563091 MLS001032098 MLS001306401 MLS002174283 Malerone Malestrone Malestrone (amps) Malogen in Oil Malogen, Aquaspension Injection Malogen, aquaspension injection Mertestate Metandren Methyltestosterone MolPort-002-506-901 NCGC00091018-01 NSC 9700 Neo-Hombreol F Neo-Testis Neo-testis Neotestis Oreton Oreton F Oreton Methyl Oreton-F Orquisteron Perandren Percutacrine Androgenique Percutacrine androgenique Primotest Primoteston Rac-17b-hydroxy-(13a)androst-4-en-3-one Rac-17b-hydroxy-(8a)-androst-4-en-3-one Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one Rac-17b-hydroxy-androst-4-en-3-one Relibra Retrotestosterone S00309 S2033_Selleck SAM001246921 SMR000058344 SMR001261453 Scheinpharm Testone-Cyp Striant Striant (TN) Sustanon Sustanone Sustason 250 Synandrol F T-Cypionate T1500_SIGMA T5411_FLUKA T5411_SIGMA TES Teslen Testamone 100 Testandrone Testaqua Testiculosterone Testim Testim (TN) Testobase Testoderm Testoderm Tts Testogel Testoject-50 Testolent Testolin Testopel Pellets Testopropon Testosteroid Testosteron Testosterona Testosterona [INN-Spanish] Testosterone Testosterone (JAN/USP) Testosterone Cypionate Testosterone Enanthate Testosterone Hydrate Testosterone [Androgenic steroids, anabolic] Testosterone [INN:BAN] Testosterone and its esters Testosterone hydrate Testosterone solution Testosteronum Testosteronum [INN-Latin] Testostosterone Testostérone Testoviron Testoviron Schering Testoviron T Testoxyl Testred Testred Cypionate 200 Testrin-P.A Testro AQ Testro Aq Testrone Testryl Tostrelle Tostrex Trans-Testosterone UNII-3XMK78S47O Viatrel Virilon Virilon IM Virormone Virosterone ZINC06500184 beta testosterone delta(sup 4)-Androsten-17(beta)-ol-3-one delta4-Androsten-17beta-ol-3-one delta4-androsten-17b-ol-3-one testosterone trans-Testosterone | |
| | 14 | | Methyltestosterone | approved | Phase 3, Early Phase 1 | 563 | 58-18-4 | 6010 | 17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one 17-Methyltestosterone 17-beta-Hydroxy-17-methylandrost-4-en-3-one 17-methyltestosterone 17alpha-Methyl-3-oxo-4-androsten-17beta-ol 17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one 17alpha-Methyltestosterone 17alpha-methyl-delta-androsten-17beta-ol-3-one 17alpha-methyltestosterone | 17beta-Hydroxy-17-methylandrost-4-en-3-one 17α-methyl-Δ4-androsten-17β-ol-3-one 17α-methyltestosterone 4-Androstene-17alpha-methyl-17beta-ol-3-one Android Methyltestosterone Methyltestosteronum Metiltestosterona NSC-9701 Testred Virilon |
| | 15 | | Fentanyl | approved, illicit, investigational, vet_approved | Phase 3 | 821 | 437-38-7 | 3345 | 1-Phenethyl-4-(N-phenylpropionamido)piperidine 1-Phenethyl-4-N-propionylanilinopiperidine 1-phenethyl-4-N-propionylanilinopiperidine 437-38-7 5-22-08-00049 (Beilstein Handbook Reference) 80832-90-2 990-73-8 (citrate) AC1L1FQ2 Actiq BIDD:GT0555 BRN 0494484 CHEBI:119915 CHEMBL596 CID3345 D00320 DB00813 Duragesic Duragesic (TN) Duragesic-100 Duragesic-12 Duragesic-25 Duragesic-50 Duragesic-75 Durogesic EINECS 207-113-6 Fentanest Fentanil Fentanil [DCIT] Fentanila Fentanila [INN-Spanish] Fentanilo Fentanyl Fentanyl (JAN/USAN/INN) Fentanyl CII Fentanyl [INN:BAN] Fentanyl citrate Fentanyl-100 Fentanyl-12 Fentanyl-25 | Fentanyl-50 Fentanyl-75 Fentanylum Fentanylum [INN-Latin] HSDB 3329 IONSYS JNS020QD L001275 LS-124439 Matrifen MolPort-003-847-369 N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide N-(1-Phenethyl-4-piperidyl)propionanilide N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide N-(1-phenethyl-4-piperidyl)propionanilide N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide N-Phenethyl-4-(N-propionylanilino)piperidine N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide N-phenethyl-4-(N-propionylanilino)piperidine N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide NCGC00168252-01 Nasalfent Oprea1_152073 Oprea1_207148 PDSP1_000860 PDSP2_000846 Pentanyl Phentanyl Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI) R 4263 Rapinyl Sentonil Sublimase Sublimaze UNII-UF599785JZ fentanyl | |
| | 16 | | Ifosfamide | approved | Phase 3, Phase 2 | 400 | 3778-73-2 | 3690 | (+-)-Ifosfamid (+-)-Ifosphamide (+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide (D,L)-Ifosfamide (R,S)-Ifosphamide (R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide 1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide 1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide 2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd 2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI) 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide 3,} 2-oxazaphosphorine oxide 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide 36341-88-5 3778-73-2 84711-20-6 A 4942 AB00513932 AC-2113 AC1L1GHW ASTA Z 4942 Ambap3778-73-2 Asta Z 4942 BPBio1_000865 BRN 0611835 BSPBio_000785 C07047 CAS-3778-73-2 CCRIS 352 CHEBI:5864 CHEMBL1024 CID3690 Cyfos D00343 D007069 DB01181 EINECS 223-237-3 HMS1570H07 HMS2090M12 HMS2093N07 HSDB 7023 Holoxan Holoxan 1000 I-Phosphamide I06-0494 IFEX (TN) Ifex Ifosfamid Ifosfamida Ifosfamida [INN-Spanish] Ifosfamide (JAN/USP/INN) | Ifosfamide Sterile Ifosfamide [USAN:INN:BAN:JAN] Ifosfamidum Ifosfamidum [INN-Latin] Ifosphamide Ifsofamide Iphosphamid Iphosphamid(e) Iphosphamide Iso Endoxan Iso-Endoxan Isoendoxan Isofosfamide Isophosphamide Isosfamide LS-102 LS-99799 MJF 9325 MJF-9325 MLS002154021 Mitoxana Mitoxana, Ifex, Ifosfamide MolPort-003-666-704 N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German] N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine NCGC00016639-01 NCGC00179435-01 NCI-C01638 NCI60_000233 NPFAPI-04 NSC 109,724 NSC 109724 NSC-109,724 NSC-109724 NSC109,724 NSC109724 Naxamide Prestwick0_000833 Prestwick1_000833 Prestwick2_000833 Prestwick3_000833 S1302_Selleck SMR001233348 SPBio_002706 STL058690 UNII-UM20QQM95Y WLN: T6NPOTJ AM2G BO B2G Z 4942 Z-4942 Z4942 ifosfamide isosfamide {3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1, | |
| | 17 | | Paclitaxel | approved, vet_approved | Phase 3, Phase 2 | 2864 | 33069-62-4 | 36314 | (2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester 12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine 157069-30-2 33069-62-4 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv. 7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv. 7-Epi-Paclitaxel 7-Epi-Taxol 7-Epipaclitaxel 7-Epitaxol 7-epi-Paclitaxel 7-epi-Taxol AB00513812 ABI 007 ABI-007 ABI007 AC-675 AC1L1IOG AC1L1VJI AC1L9AVF ACon1_002231 ANX-513 Abraxane Abraxane (TN) Abraxane I.V. Suspension Abraxis BioScience brand of albumin-bound paclitaxel Ambotz33069-62-4 Anzatax Asotax BIDD:PXR0046 BMS 181339-01 BMS-181339 BMS-181339-01 BPBio1_000320 BRD-A23723433-001-01-2 BRD-A28746609-001-04-0 BRD-K62008436-001-03-1 BSPBio_000290 BSPBio_001152 BSPBio_002614 Bio-0076 Bio1_000362 Bio1_000851 Bio1_001340 Bio2_000416 Bio2_000896 Bristaxol C07394 C466458 C47H51NO14 CCRIS 8143 CHEBI:103439 CHEBI:45863 CHEMBL100910 CHEMBL418410 CHEMBL48 CID36314 CID441276 CID4666 CID6713921 CID6915727 CPD-8718 Capxol D00491 DB01229 DHP-107 DHP-208 DRG-0190 DTS-301 DivK1c_000441 EU-0101201 Ebetaxel EmPAC Epitaxol Genaxol Genetaxyl Genexol Genexol-PM HMS1362J13 HMS1568O12 HMS1792J13 HMS1922K08 HMS1990J13 HMS2090D07 HMS2093K15 HMS501G03 HSDB 6839 I06-0014 IDI1_000441 IDI1_002171 Intaxel KBio1_000441 KBio2_000492 KBio2_002016 KBio2_002509 KBio2_003060 KBio2_004584 KBio2_005077 KBio2_005628 KBio2_007152 KBio2_007645 KBio3_000903 KBio3_000904 KBio3_001834 KBio3_002987 KBioGR_000492 KBioGR_001893 | KBioGR_002509 KBioSS_000492 KBioSS_002016 KBioSS_002517 LMPR0104390001 LS-31070 LipoPac Lopac0_001201 MBT 0206 MEGxp0_001940 MLS000863266 MLS001077297 MLS002154218 MLS002172439 MLS002695976 MPI-5018 Micellar Paclitaxel Mitotax MolPort-001-742-627 MolPort-003-665-783 MolPort-003-932-365 NCGC00024995-02 NCGC00024995-03 NCGC00024995-04 NCGC00024995-05 NCGC00024995-06 NCGC00024995-07 NCGC00164367-01 NCGC00164367-02 NCGC00164367-03 NCI60_000601 NINDS_000441 NK 105 NP-010981 NSC 125973 NSC-125973 NSC125973 NSC358882 Nanotaxel Neuro_000060 Nova-12005 OAS-PAC-100 OncoGel Onxal Onxol Onxol, Taxol, Nov-Onxol, Paclitaxel P1632 Paclical Pacligel Paclitaxel Paclitaxel (JAN/USP) Paclitaxel (JAN/USP/INN) Paclitaxel (Taxol) Paclitaxel [USAN:INN:BAN] Paxceed Paxene Paxoral Plaxicel Praxel Prestwick0_000155 Prestwick1_000155 Prestwick2_000155 Prestwick3_000155 Probes2_000350 QW 8184 S-8184 Paclitaxel Injectable Emulsion S1150_Selleck SDCCGMLS-0066823.P001 SDP-013 SMP1_000228 SMR000394086 SMR000857385 SPBio_000943 SPBio_002229 SPECTRUM1503908 ST50306996 Spectrum2_000872 Spectrum3_001057 Spectrum4_001197 Spectrum5_001491 Spectrum_001536 T 7402 T1912_SIGMA T7191_SIGMA T7402_SIGMA TA1 TAXOL (TN) TAXOL, 10-EPI, TXL TaxAlbin Taxol Taxol A Taxol Konzentrat Taxol.RTM. (Registered Trademark) UNII-P88XT4IS4D UPCMLD-DP108:001 UPCMLD-DP108:002 Vascular Wrap Xorane Yewtaxan abi-007 albumin-bound paclitaxel cMAP_000068 nab-paclitaxel nchembio.188-comp1 nchembio.2007.34-comp9 nchembio.215-comp9 nchembio853-comp6 paclitaxel weekly paclitaxel |
| | 18 | | Mechlorethamine | approved | Phase 3, Phase 2 | 397 | 51-75-2 | 4033 | .Beta.,.beta.'-Dichlorodiethyl-N-methylamine 1, 5-Dichloro-3-methyl-3-azapentane hydrochloride 126-85-2 (N-oxide) 2,2'-Dichloro-N-me 2,2'-Dichloro-N-methyldiethylamine 2,2'-Dichlorodiethyl-methylamine 2,2'-dichloro-N-methyldiethylamine 2-Chloro-N-(2-chloroethyl)-N-methylethanamine 302-70-5 (N-oxide, hydrochloride) 51-75-2 55-86-7 (HYDROCHLORIDE) AC1L1H9H Antimit BRN 0605323 BSPBio_001947 Bis(2-chloroethyl)methylamine Bis(beta-chloroethyl) methylamine Bis(beta-chloroethyl)methylamine C07115 C5H11Cl2N CCRIS 447 CHEBI:28925 CHEMBL427 CID4033 Carolysine Caryolysin Caryolysine Chloramine (the nitrogen mustard) Chlorethazine Chlormethine Chlormethine (INN) Chlormethine [INN:BAN] Chlormethinum [INN-Latin] Cloramin Clormetina Clormetina [INN-Spanish] D07671 DB00888 Di(2-chloroethyl)methylamine Dichlor amine Dichloren DivK1c_000759 EINECS 200-120-5 ENT-25294 Embechine Embichin HMS1920J15 HMS2091B04 HMS502F21 HN-2 HN2 HSDB 5083 I14-8708 IBS-L0033631 IDI1_000759 KBio1_000759 KBio2_001369 KBio2_003937 KBio2_006505 KBio3_001447 | KBioGR_001448 KBioSS_001369 LS-7559 MBA Me chloroethamine Mebichloramine Mechlorethamine Mechlorethanamine Mechloroethamine Mecloretamina Mecloretamina [Italian] Methylbis(2-chloroethyl)amine Methylbis(beta-chloroethyl)amine Methyldi(2-chloroethyl)amine Mitoxine (*Hydrochloride*) MolPort-001-785-592 Mustargen Mustine Mustine note Mutagen N,N-Bis(2-chloroethyl)-N-methylamine N,N-Bis(2-chloroethyl)methylamine N,N-Di(chloroethyl)methylamine N-Lost N-Methyl lost N-Methyl-2,2'-dichlorodiethylamine N-Methyl-bis(2-chloroethyl)amine N-Methyl-bis(beta-chloroethyl)amine N-Methyl-bis-chloraethylamin N-Methyl-bis-chloraethylamin [German] N-Methyl-lost N-Methyl-lost [German] N-methyl-bis(2-chloroethyl)amine NCGC00091835-02 NCGC00091835-03 NCGC00091835-04 NCGC00091835-05 NCI60_041682 NINDS_000759 NSC762 Nitol (*Hydrochloride*) Nitrogen mustard Nitrogen mustard (HN-2) Nitrogranulogen SPBio_000496 SPECTRUM1500375 Spectrum2_000448 Spectrum3_000484 Spectrum4_000924 Spectrum5_001702 Spectrum_000889 Stickstofflost (*Hydrochloride*) Stickstofflost (ebewe) T 1024 T-1024 TL 146 UNII-50D9XSG0VR beta,Beta'-dichlorodiethyl-N-methylamine beta,beta'-Dichlorodiethyl-N-methylamine mechlorethamine thyldiethylamine β,β'-dichlorodiethyl-N-methylamine |
| | 19 | | Cisplatin | approved | Phase 3, Phase 2, Phase 1 | 2770 | 15663-27-1 | 84093, 441203, 2767 | (SP-4-1)-diamminedichloridoplatinum (SP-4-1)-diamminedichloroplatinum (SP-4-2)-diamminedichloridoplatinum (SP-4-2)-diamminedichloroplatinum Abiplatin Biocisplatinum Briplatin CACP CDDP CHEBI:35852 CID441203 CPD0-1392 CPDC CPDD Carboquone Cis Pt II Cis-DDP Cis-Diaminedichloroplatinum Cis-Diamminedichloroplatinum Cismaplat Cisplatine Cisplatino Cisplatinum Cisplatyl Citoplationo DB00515 DDP DDPT Diamminedichloroplatinum | EU-0100918 Lederplatin Neoplatin Peyrone's chloride Peyrone's salt Plastin Platamine Platiblastin Platidiam Platinex Platinol Platinol-AQ Platinoxan Platinum Ammine Chloride Platinum Ammonium Chloride Platinum Diamine Dichloride Randa Trans-DDP Trans-Diaminedichloroplatinum Trans-Diamminedichloroplatinum Trans-Dichlorodiammine Platinum Trans-Platinumdiammine Dichloride cis-DDP cis-Diamminedichloroplatinum cis-Dichlorodiammineplatinum(II) cis-[PtCl2(NH3)2] cis-diamminedichloridoplatinum(II) cis-diamminedichloroplatinum(II) nchembio773-comp1 trans-diamminedichloridoplatinum(II) | |
| | 20 | | Propofol | approved, investigational, vet_approved | Phase 3 | 1082 | 2078-54-8 | 4943 | 2, 6-Diisopropylphenol 2,6 Diisopropylphenol 2,6-Bis(1-methylethyl)phenol 2,6-Bis(Isopropyl)-phenol 2,6-DIISOPROPYLPHENOL 2,6-Diisopropyl phenol 2,6-Diisopropylphenol 2,6-bis(1-methylethyl)-phenol 2,6-di(propan-2-yl)phenol 2078-54-8 28449-97-0 4-06-00-03435 (Beilstein Handbook Reference) 50356-15-5 AB00513968 AC-2038 AC1L1J9Y AC1Q1OUI AI3-26295 AM-149 Abbott Brand of Propofol Alpha Brand of Propofol Ampofol Aquafol Astra Brand of Propofol AstraZeneca Brand of Propofol BIDD:GT0436 BPBio1_000950 BPBio1_000969 BRD-K82255054-001-03-5 BRN 1866484 BSPBio_000862 Biomol-NT_000248 Braun Brand of Propofol C07523 C12H18O CAS-2078-54-8 CCRIS 9000 CHEBI:44915 CHEMBL526 CID4943 CPD-11437 CPD000059151 Curamed Brand of Propofol D00549 D015742 D0617 D126608 D126608_ALDRICH DB00818 DDS-04F Diisopropylphenol Dipravan Diprivan Diprivan (TN) Diprivan Injectable emulsion Disoprivan Disoprofol EINECS 218-206-6 EU-0100437 Fresenius Brand of Propofol Fresenius Kabi Brand of Propofol Fresofol HMS1570L04 HMS2089O21 HMS2094E17 | HSDB 7123 ICI 35,868 ICI 35868 ICI-35,868 ICI-35868 ICI35,868 ICI35868 InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H Ivofol Jsp004266 Juste Brand of Propofol LS-996 Lopac-D126608 Lopac0_000437 MLS001066348 MLS001335999 MLS002454360 MolPort-001-794-517 NCGC00015389-01 NCGC00015389-02 NCGC00015389-04 NCGC00015389-09 NCGC00091538-01 NCGC00091538-02 NCGC00091538-03 NCGC00091538-04 NCGC00091538-05 NCGC00091538-06 NSC 5105 NSC5105 PFL Parnell Brand of Propofol Pisa Brand of Propofol Prestwick0_000931 Prestwick1_000931 Prestwick2_000931 Prestwick3_000931 Propofol Propofol (JAN/USAN/INN) Propofol Abbott Propofol Fresenius Propofol IDD-D Propofol MCT Propofol Rovi Propofol [USAN:INN:BAN] Propofol(2,6-Diisopropylphenol) Propofol-Lipuro Propofolum Propofolum [Latin] Rapinovet Recofol Rovi Brand of Propofol S01-0189 SAM002264610 SMR000059151 SPBio_003031 SPECTRUM1505022 ST50405911 Schering Brand of Propofol UNII-YI7VU623SF W505102_ALDRICH ZD-0859 ZINC00968303 Zeneca Brand of Propofol ghl.PD_Mitscher_leg0.558 nchembio.552-comp7 propofol |
| | 21 | | Clonidine | approved | Phase 3 | 240 | 4205-90-7 | 2803 | 1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- (9CI) 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine 2,6-dichloro-N-(2-imidazolidinylidene)aniline 2,6-dichloro-N-2-imidazolidinylidenebenzenamide 2,6-dichloro-N-imidazolidin-2-ylideneaniline 2-((2,6-Dichlorophenyl)imino)imidazolidine 2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2) 2-(2,6-Dichloroanilino)-2-imidazoline 2-(2,6-Dichlorophenylamino)-2-imidazoline 2-(2,6-Dichlorophenylimino)imidazolidine 2-Imidazoline, 2-(2,6-dichloroanilino)- (7CI,8CI) 2-[(2,6-Dichlorophenyl)imino]imidazoline 2-[(2,6-dichlorophenyl)imino]-2-imidazoline 4205-90-7 4205-91-8 (mono-hydrochloride) 57066-25-8 734571A AB00514634 AC1L1EI5 AC1Q3K6V AKOS001595470 Adesipress BIDD:GT0547 BPBio1_000040 BRD-K98530306-001-02-1 BRD-K98530306-003-05-0 BSPBio_000036 BSPBio_001588 BSPBio_002055 Bio1_000470 Bio1_000959 Bio1_001448 Bio2_000308 Bio2_000788 C9H9Cl2N3 CAS-4205-91-8 CATAPRES-TTS-1 CATAPRES-TTS-2 CATAPRES-TTS-3 CCRIS 7787 CHEBI:3757 CHEBI:46632 CHEMBL134 CID2803 Catapres Catapres- TTS Catapres-TTS Catapresan Catapressan Catarpres Catarpres-TTS Catarpres-TTS (TN) Catarpresan Chlofazoline Chlornidinum Clofenil Clonidin Clonidina Clonidina [INN-Spanish] Clonidine (JAN/USAN/INN) Clonidine HCl Clonidine [USAN:BAN:INN] Clonidinhydrochlorid Clonidinum Clonidinum [INN-Latin] Clonistada Clopheline D00281 DB00575 DB07566 DivK1c_000774 | Dixarit Duraclon Duraclont EINECS 224-119-4 Gemiton HMS1361P10 HMS1791P10 HMS1989P10 HMS2089G11 HSDB 3040 Hemiton IDI1_000774 IDI1_034058 Ipotensium Isoglaucon KBio1_000774 KBio2_000308 KBio2_001821 KBio2_002876 KBio2_004389 KBio2_005444 KBio2_006957 KBio3_000615 KBio3_000616 KBio3_001275 KBioGR_000308 KBioGR_001572 KBioSS_000308 KBioSS_001821 Klofelin Klofenil L000193 LS-79606 Lopac-C-7897 Lopac0_000268 M 5041T M-5041T MolPort-001-779-668 MolPort-005-932-374 N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine NCGC00015268-01 NCGC00015268-02 NCGC00015268-08 NCGC00024734-01 NCGC00024734-02 NCGC00024734-03 NCGC00024734-04 NCGC00024734-05 NCGC00179680-01 NINDS_000774 Prestwick0_000248 Prestwick1_000248 Prestwick2_000248 Prestwick3_000248 SKF 34427 SPBio_001233 SPBio_002255 ST 155BS ST-155-BS ST-155BS Spectrum2_001187 Spectrum3_000358 Spectrum4_000956 Spectrum5_000759 Spectrum_001341 T171 Tenso-Timelets Tocris-0690 UNII-MN3L5RMN02 ZINC00896484 clonidine nchembio.79-comp11 nchembio705-10 |
| | 22 | | Dexamethasone | approved, investigational, vet_approved | Phase 3 | 2171 | 50-02-2 | 5743 | (3H)-Dexamethasone .delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol .gamma.corten 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone 1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone 1-Dehydro-16α-methyl-9α-fluorohydrocortisone 137098-19-2 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone 16-alpha-Methyl-9-alpha-fluoroprednisolone 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol 16alpha -Methyl-9alpha -fluoroprednisolone 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone 16alpha-Methyl-9alpha-fluoroprednisolone 16α-Methyl-9α-fluoro-1-dehydrocortisol 23495-06-9 31375_FLUKA 46165_FLUKA 46165_RIEDEL 50-02-2 8054-59-9 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione 9-Fluoro-16-methylprednisolone 9-alpha-Fluoro-16-alpha-methylprednisolone 9.alpha.-Fluoro-16.alpha.-methylprednisolone 906422-84-2 9A-FLUORO-16BETA-METHYLPREDNISOLONE 9alpha -Fluoro-16alpha -methylprednisolone 9alpha-Fluoro-16alpha-methylprednisolone 9alpha-fluoro-16alpha-methyl-Prednisolone 9α-Fluoro-16α-methylprednisolone AC-11056 AC1L1L1H AC1Q29DM AI3-50934 Adexone Aeroseb-D Aeroseb-Dex Aeroseb-dex Ak Dex Oph Otic Soln 0.1% Alcon Brand of Dexamethasone Anaflogistico Aphtasolon Aphthasolone Apo-dexamethasone Auxiron Azimycin (veterinary) Azium Azium (Veterinary) Azium (veterinary) BIDD:ER0494 BIDD:PXR0060 BRD-K38775274-001-02-3 BRD-K38775274-001-06-4 BSPBio_000995 Bisu DS Bisu Ds C15643 C22H29FO5 CCRIS 7067 CHEBI:41879 CHEMBL384467 CID5743 CPD-10549 CPD001227192 Calonat Corson Corsone Cortisumman D00292 D003907 D1756_SIGMA D4902_SIGMA D6645_SIGMA D8893_SIGMA D9184_SIGMA DB01234 DEX DEXA DEXONE 0.5 DEXONE 0.75 DEXONE 1.5 DEXONE 4 DXM DXMS Decacort Decacortin Decaderm Decadron Decadron (TN) Decadron Tablets, Elixir Decadron, Dexamethasone Decadron-LA Decadron-La Decagel Decaject Decaject L.A. Decaject-L.A. Decalix Decameth Decasone Decaspray Dectancyl Dekacort Delta1-9alpha-Fluoro-16alpha-methylcortisol Deltafluorene Dergramin Deronil Desadrene Desametasone Desametasone [DCIT] Desametasone [Dcit] Desamethasone Desameton Deseronil Dex-Ide Dex-ide Dexa Dexa Mamallet Dexa mamallet Dexa-Cortidelt Dexa-Cortisyl Dexa-Mamallet Dexa-Scheroson Dexa-Sine Dexa-cortidelt Dexa-cortisyl Dexa-scheroson Dexa-sine Dexacen-4 Dexacidin Dexacort Dexacortal Dexacortin Dexadeltone Dexafarma Dexair Dexalona Dexaltin Dexametasona Dexametasona [INN-Spanish] Dexametasone | Dexameth Dexamethansone Dexamethasone Dexamethasone (JP15/USP/INN) Dexamethasone Acetate Dexamethasone Alcohol Dexamethasone Base Dexamethasone Intensol Dexamethasone Sodium Phosphate Dexamethasone [INN:BAN:JAN] Dexamethasone alcohol Dexamethasone base Dexamethasone intensol Dexamethasone-omega Dexamethasonum Dexamethasonum [INN-Latin] Dexamethazone Dexamonozon Dexapolcort Dexapos Dexaprol Dexason Dexasone Dexasone 0.5mg Dexasone 0.75mg Dexasone 4mg Dexasporin Dexinolon Dexinoral Dexone Dexone 0.5 Dexone 0.75 Dexone 1.5 Dexone 4 Dexonium Dexpak Dextelan Dezone Dinormon Dxms ECR Brand of Dexamethasone EINECS 200-003-9 FT-0080377 Fluormethylprednisolone Fluormone Fluorocort Fortecortin Foy Brand of Dexamethasone Gammacorten HL-dex HMS1792A17 HMS1990A17 HMS2089N13 HSDB 3053 Hexadecadrol Hexadrol Hexadrol Elixir Hexadrol Tablets Hexadrol elixir Hl-Dex Hl-dex I06-1196 ICN Brand of Dexamethasone IontoDex Isopto-Dex Isopto-dex LS-7300 Lokalison F Lokalison f Loverine Luxazone MK 125 MLS001055412 MLS001332507 MLS001332508 Maxidex Maxidex Ont 0.1% Maxidex Sus 0.1% Maxitrol Mediamethasone Merck Brand of Dexamethasone Merz Brand 1 of Dexamethasone Merz Brand 2 of Dexamethasone Methylfluorprednisolone Mexidex Millicorten MolMap_000018 MolPort-003-846-433 Mymethasone NCGC00091019-01 NCGC00091019-02 NCGC00091019-03 NCGC00091019-04 NCGC00091019-05 NCI60_003067 NSC 34521 NSC34521 Naquasone (veterinary) Neomycin and polymyxin b sulfates and dexamethasone Neomycin and polymyxin b sulphates and dexamethasone OTO-104 Ocu-Trol Ocu-trol Oradexon PHL-dexamethasone PMS-dexamethasone Pet Derm III Pet Derm Iii Pet derm III Pet-Derm Iii Pms Dexamethasone Elixir 0.5mg/5ml Policort Posurdex Prednisolon F Prednisolon f Prednisolone F Prednisolone f Prodex S1322_Selleck SAM002548948 SGCUT00126 SK-Dexamethasone SK-dexamethasone SMP1_000092 SMR000857119 SMR001227192 ST50307091 Sandoz dexamethasone Sk-Dexamethasone Spectrum5_002019 Spoloven Sunia Sol D Sunia sol D Superprednol TL8003317 Tobradex Tobramycin and dexamethasone Tresaderm (veterinary) Turbinaire UNII-7S5I7G3JQL Visumetazone WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1 ZINC03875332 alpha -Fluoro-16-alpha -methylcortisol delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta1-9alpha-Fluoro-16alpha-methylcortisol dexamethasone nchembio809-comp2 to_000038 |
| | 23 | | Ropivacaine | approved | Phase 3 | 793 | 84057-95-4 | 71273, 175805 | (2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide (2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride (S)-(−)-1-propyl-2',6'-pipecoloxylidide (S)-ropivacaine 84057-95-4 98717-15-8 AC1L41QM AC1L41QN BIDD:GT0203 C07532 C17H26N2O.HCl CHEBI:8890 CHEMBL1077896 CID175804 CID175805 CPD000469137 D08490 I14-176 L-N-n-propylpipecolic acid-2,6-xylidide LS-113954 | MLS001401363 MolPort-003-983-292 NCGC00164597-01 Naropin Naropin (TN) ROPIVACAINE HCl Ropivacaina Ropivacaina [INN-Spanish] Ropivacaina [Spanish] Ropivacaine Ropivacaine [INN] Ropivacaine hydrochloride Ropivacaine monohydrochloride Ropivacainum Ropivacainum [INN-Latin] S-Ropivacaine SAM001246524 SMR000469137 ST51051452 ropivacaine monohydrochloride, ropivacaine monohydrochloride, (S)-isomer | |
| | 24 | | Epinephrine | approved, vet_approved | Phase 3 | 985 | 51-43-4 | 5816 | (-)-(R)-Epinephrine (-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol (-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol (-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol (-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol (-)-Adrenalin (-)-Adrenaline (-)-Epinephrine (-)-R-Epinephrine (R)-(-)-Adnephrine (R)-(-)-Adrenaline (R)-(-)-Epinephrine (R)-(-)-Epirenamine (R)-(−)-adrenaline (R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol (R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol (R)-Adrenaline (R)-Epinephrine (−)-adrenaline 02252_FLUKA 1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol 1-Adrenalin 1-Epinephrine 4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol 4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol 51-43-4 51-43-4 (FREE BASE) 51028-73-0 A0173 AC-13188 AC1L1L7B ADR ADRENALINE ADROP AI3-19015 Adnephrine Adrenal Adrenalin Adrenalin (TN) Adrenalin in Oil Adrenalin-Medihaler Adrenalina Adrenalina [DCIT] Adrenaline Adrenaline (JP15) Adrenaline/Epinephrine Adrenalinum Adrenamine Adrenan Adrenapax Adrenasol Adrenatrate Adrenine Adrenodis Adrenohorma Adrenosan Adrenutol Adrin Adrine Ana-Guard Ana-Kit Antiasthmatique Asmatane Mist Asthma meter mist Asthma-nefrin Asthmahaler Mist Asthmanefrin Astmahalin Astminhal BIDD:GT0119 Balmadren Bernarenin Biorenine Bosmin Brevirenin Bronkaid Bronkaid Mist Bronkaid Suspension Mist Bupivacaine Hcl and Epinephrine C00788 CCRIS 4812 CHEBI:28918 CHEMBL679 CID5816 Chelafrin Citanest Forte Corisol D-Epifrin D-Epinephrine D00095 DB00668 Drenamist Dylephrin Dyspne-Inhal E4250_SIGMA EINECS 200-098-7 EPI E Z PEN JR EPIPEN E Z PEN EPIPEN JR Epi EZ Pen Jr Epifrin Epiglaufrin Epinefrin Epinefrin [Czech] Epinefrina Epinefrina [INN-Spanish] Epinephran Epinephrin Epinephrine Epinephrine (USP) Epinephrine (USP/INN) Epinephrine [USAN:INN:JAN] Epinephrine hydrochloride Epinephrinum Epinephrinum [INN-Latin] Epipen Epipen (TN) Epipen Auto-Injector Epipen EZ Pen Epipen Jr. Epipen Jr. Auto-Injector Epirenamine Epirenan Epirenin Epitrate Eppy Esphygmogenina Exadrin | Glaucon Glaucosan Glauposine Glycirenan HSCI1_000215 HSDB 4289 Haemostasin Haemostatin Hektalin Hemisine Hemostasin Hemostatin Hypernephrin Hyporenin IOP Intranefrin Iontocaine Isoptoepinal Kidoline L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol L-Adrenaline L-Adrenaline Base L-Epinehphrine L-Epinephrine L-Epirenamine L-Methylaminoethanolcatechol L-epinephrine LS-156 Levo-Methylaminoethanolcatechol Levoadrenaline Levoepinephrine Levorenen Levorenin Levorenine Levoreninum Lopac-E-4642 Lyodrin Lyophrin Medihaler-Epi Metanephrin Methylaminoethanolcatechol Methylarterenol Micronefrin Micronephrine MolPort-002-051-368 Mucidrina Myosthenine Mytrate NCGC00015417-01 NCGC00142615-01 NCGC00142615-03 NCGC00142615-04 NCGC00142615-05 NCGC00142615-06 NCGC00142615-07 NSC 62786 NSC62786 Nephridine Nieraline PDSP1_001120 PDSP2_001104 Paranephrin Primatene Primatene Mist R-(-)-Epinephrine R-Adrenaline RCRA waste no. P042 Racemic Epinephrine Racepinephrine Rcra waste number P042 Renagladin Renaglandin Renaglandulin Renaleptine Renalina Renoform Renostypricin Renostypticin Renostyptin SMP1_000227 ST069368 SUS-PHRINE SULFITE-FREE Scurenaline Septocaine Simplene Sindrenina Soladren Sphygmogenin Stryptirenal Styptirenal Supracapsulin Supradin Supranefran Supranephrane Supranephrine Supranol Suprarenaline Suprarenin Suprel Surenine Surrenine Sus-Phrine Sus-phrine Susphrine Sympathin I Takamina Takamine Tokamina Tonogen Twinject Twinject 0.15 Twinject 0.3 Twinject 0.30 UNII-YKH834O4BH Vaponefrin Vasoconstrictine Vasoconstrictor Vasodrine Vasoton Vasotonin adrenaline bmse000316 d-Adrenaline epinephrine l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol l-Adrenalin l-Adrenaline l-Epinephine l-Epinephrine (synthetic) l-Epirenamine l-Methylaminoethanolcatechol levoepinephrine nchembio747-comp9 |
| | 25 | | Benzocaine | approved | Phase 3 | 2016 | 1994-09-7, 94-09-7 | 2337 | (p-(Ethoxycarbonyl)phenylamine 06952_FLUKA 112909_ALDRICH 112909_SIAL 1333-08-0 23239-88-5 23239-88-5 (hydrochloride) 4 Aminobenzoic Acid Ethyl Ester 4-(Ethoxycarbonyl)aniline 4-(Ethoxycarbonyl)phenylamine 4-14-00-01129 (Beilstein Handbook Reference) 4-Aminobenzoate 4-Aminobenzoic acid 4-Aminobenzoic acid ethyl ester 4-Aminobenzoic acid, ethyl ester 4-Carbethoxyaniline 4-amino-benzoic acid ethyl ester 4-aminobenzoic acid ethyl ester 71123-91-6 94-09-7 94-09-7 (Parent) A0271 AB00051923 AC1L1DGC AC1Q341A AC1Q64JE AE-562/40377256 AI3-02081 AKOS000119763 AR-1H9065 Acetate, Benzocaine Aethoform Aethylium paraminobenzoicum Amben ethyl ester Americaine Anaesthan-syngala Anaesthesin Anaesthesinum Anaesthin Anestezin Anestezin [Russian] Anesthesin Anesthesine Anesthone BB_SC-0019 BPBio1_001017 BRD-K75466013-001-05-2 BRN 0638434 BSPBio_000923 BSPBio_001908 Baby Anbesol Bensokain Benzoak Benzocaina Benzocaina [INN-Spanish] Benzocaine Benzocaine (USP/INN) Benzocaine Acetate Benzocaine Formate Benzocaine Hydrobromide Benzocaine Hydrochloride Benzocaine Methanesulfonate Benzocaine [INN:BAN] Benzocainum Benzocainum [INN-Latin] Benzoic acid, 4-amino-, ethyl ester Benzoic acid, 4-amino-, ethyl ester, hydrochloride Benzoic acid, amino-, ethyl ester Benzoic acid, p-amino-, ethyl ester C07527 CAS-94-09-7 CHEBI:116735 CHEMBL278172 CID2337 Caswell No. 430A Chloraseptic D001566 D00552 DB01086 Dermoplast Diet Ayds DivK1c_000932 E1501_SIGMA EINECS 202-303-5 EPA Pesticide Chemical Code 097001 ETHYL-P-AMINOBENZOATE Ethoform Ethoforme Ethyl 4-aminobenzoate Ethyl 4-aminobenzoate hydrochloride Ethyl 4-aminobenzoic acid Ethyl Aminobenzoate Ethyl PABA | Ethyl aminobenzoate Ethyl aminobenzoate (JP15) Ethyl aminobenzoate (VAN) Ethyl aminobenzoic acid Ethyl p-Aminobenzoate Ethyl p-Aminophenylcarboxylate Ethyl p-aminobenzenecarboxylate Ethyl p-aminobenzoate Ethyl p-aminobenzoic acid Ethyl p-aminophenylcarboxylate Ethylester kyseliny p-aminobenzoove Ethylester kyseliny p-aminobenzoove [Czech] Ethylis aminobenzoas Formate, Benzocaine HMS1570O05 HMS1920G09 HMS2091M11 HMS502O14 HSDB 7225 Hurricaine Hydrobromide, Benzocaine Hydrochloride, Benzocaine I05-0204 IDI1_000932 Identhesin KBio1_000932 KBio2_000474 KBio2_003042 KBio2_005610 KBio3_001408 KBioGR_000658 KBioSS_000474 Keloform LS-35847 MLS001331704 MLS002153970 Methanesulfonate, Benzocaine MolPort-000-871-526 NCGC00016352-01 NCGC00094598-01 NCGC00094598-02 NINDS_000932 NSC 122792 NSC 41531 NSC41531 NSC4688 Norcain Norcaine Norcainum Oprea1_750694 Oprea1_827402 Ora-jel Orabase-B Orthesin Otocain Outgro Parathesin Parathesin (TN) Parathesine Prestwick0_000712 Prestwick1_000712 Prestwick2_000712 Prestwick3_000712 Prestwick_991 SMR000059025 SPBio_000134 SPBio_002844 SPECTRUM1500139 STK043620 Slim Mint Gum Solarcaine Solu H Spectrum2_000117 Spectrum3_000314 Spectrum4_000249 Spectrum5_000860 Spectrum_000074 Topcaine UNII-U3RSY48JW5 WLN: ZR DVO2 ZINC12358719 benzocaine ethylaminobenzoate-4 h-4-abz-oet nchembio.182-comp4 p-(Ethoxycarbonyl)aniline p-Aminobenzoate p-Aminobenzoic acid p-Aminobenzoic acid ethyl ester p-Aminobenzoic acid, ethyl ester p-Aminobenzoic ethyl ester p-Carbethoxyaniline p-Ethoxycarboxylic Aniline p-Ethoxycarboxylic aniline | |
| | 26 | | tannic acid | approved, Nutraceutical | Phase 3 | 2016 | | | | 27 | | protease inhibitors | | Phase 3, Phase 2 | 5471 | | | | | 28 | | HIV Protease Inhibitors | | Phase 3, Phase 2 | 5470 | | | | 29 | | Liver Extracts | | Phase 3, Phase 2, Phase 1 | 4067 | | | | 30 | | Antineoplastic Agents, Phytogenic | | Phase 3, Phase 2 | 5602 | | | | 31 | | Isophosphamide mustard | | Phase 3, Phase 2 | 400 | | | | 32 | | Anesthetics | | Phase 3, Phase 1, Phase 2 | 9596 | | | | 33 | | Analgesics, Opioid | | Phase 3 | 3238 | | | | 34 | | Antineoplastic Agents, Alkylating | | Phase 3, Phase 2, Phase 1 | 4603 | | | | 35 | | Alkylating Agents | | Phase 3, Phase 2, Phase 1 | 4827 | | | | 36 | | Neurotransmitter Agents | | Phase 3 | 18340 | | | | 37 | | Adjuvants, Anesthesia | | Phase 3 | 1674 | | | | 38 | | Albumin-Bound Paclitaxel | | Phase 3, Phase 2 | 2864 | | | | 39 | | Antimitotic Agents | | Phase 3, Phase 2 | 5657 | | | | 40 | | Analgesics | | Phase 3, Phase 2 | 11733 | | | | 41 | | Narcotics | | Phase 3 | 3646 | | | | 42 | | Hormone Antagonists | | Phase 3, Early Phase 1 | 13180 | | | | 43 | | Central Nervous System Depressants | | Phase 3, Phase 1, Phase 2 | 13403 | | | | 44 | | Chelating Agents | | Phase 3 | 1423 | | | | 45 | | Calcium, Dietary | | Phase 3 | 5713 | | | | 46 | | Anticoagulants | | Phase 3 | 2623 | | | | 47 | | pancreatic polypeptide | | Phase 3 | 20 | | | | 48 | | Peripheral Nervous System Agents | | Phase 3, Phase 2, Phase 1 | 23689 | | | | 49 | | Hormones | | Phase 3, Early Phase 1 | 14415 | | | | 50 | | Testosterone 17 beta-cypionate | | Phase 3, Early Phase 1 | 563 | | |
Interventional clinical trials: (show top 50)
(show all 100)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | The Efficacy of Penile Rehabilitation Using Udenafil After Total Mesorectal Excision of Rectal Cancer | Completed | NCT01421940 | Phase 4 | | 2 | Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer | Completed | NCT01511874 | Phase 4 | | 3 | A Study of Tadalafil After Radical Prostatectomy | Completed | NCT01026818 | Phase 4 | | 4 | Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer. | Recruiting | NCT02001857 | Phase 4 | | 5 | Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study | Recruiting | NCT01824537 | Phase 4 | | 6 | Concurrent Chemoradiation Versus Wide Pelvic Lymphadenectomy for Advanced Rectal Cancer | Unknown status | NCT00154752 | Phase 3 | | 7 | Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City | Unknown status | NCT02382900 | Phase 3 | | 8 | Mechanical Nerve Stimulation in the Treatment of Post Prostatectomy Incontinence | Unknown status | NCT01540656 | Phase 3 | | 9 | Evaluating the Effect of the VCD on Erectile Function and Penile Length Post RRP | Completed | NCT00177125 | Phase 3 | | 10 | Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial | Completed | NCT00247312 | Phase 3 | | 11 | An Investigational Study of Gardasil™ (qHPV, V501) Vaccine in Reducing the Incidence of Anogenital Warts in Young Men (V501-020) | Completed | NCT00090285 | Phase 3 | | 12 | Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain | Completed | NCT00538850 | Phase 3 | | 13 | Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer | Completed | NCT00142506 | Phase 3 | | 14 | Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate | Completed | NCT00632138 | Phase 3 | | 15 | Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy | Completed | NCT00895011 | Phase 3 | | 16 | A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018) | Completed | NCT00092547 | Phase 3 | | 17 | Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts | Completed | NCT00449982 | Phase 3 | | 18 | Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis | Recruiting | NCT02740127 | Phase 3 | | 19 | Efficacy and Tolerability Study of V501 in Japanese Males (V501-122) | Active, not recruiting | NCT01862874 | Phase 3 | | 20 | International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) | Not yet recruiting | NCT02305654 | Phase 3 | | 21 | Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer? | Terminated | NCT00215631 | Phase 3 | | 22 | Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET] | Unknown status | NCT02104063 | Phase 2 | | 23 | External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases | Unknown status | NCT00637637 | Phase 2 | | 24 | High-Intensity Focused Ultrasound in Treating Patients With Localized Prostate Cancer | Unknown status | NCT01194648 | Phase 2 | | 25 | A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis | Completed | NCT03114254 | Phase 2 | | 26 | Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer | Completed | NCT00066391 | Phase 2 | | 27 | Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis | Completed | NCT00512096 | Phase 2 | | 28 | Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers | Completed | NCT01585428 | Phase 2 | | 29 | T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers | Completed | NCT02280811 | Phase 2 | | 30 | Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | Completed | NCT00002506 | Phase 2 | | 31 | Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma | Completed | NCT00210041 | Phase 2 | | 32 | Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer | Completed | NCT00039624 | Phase 2 | | 33 | Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction | Completed | NCT01089387 | Phase 1, Phase 2 | | 34 | Immune Therapy of HPV-induced Cancers | Completed | NCT01462838 | Phase 1, Phase 2 | | 35 | Oral Rigosertib for Squamous Cell Carcinoma | Completed | NCT01807546 | Phase 2 | | 36 | Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis | Recruiting | NCT01728233 | Phase 2 | | 37 | Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma | Recruiting | NCT02837042 | Phase 2 | | 38 | Role of Low-intensity Shock Wave Therapy in Penile Rehabilitation Post Nerve Sparing Radical Cysto-prostatectomy | Recruiting | NCT02422277 | Phase 2 | | 39 | Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma | Recruiting | NCT02541903 | Phase 2 | | 40 | An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors | Recruiting | NCT02488759 | Phase 1, Phase 2 | | 41 | Study for the Evaluation of Efficacy of Pembrolizumab (MK-3475) in Patients With Rare Tumors | Recruiting | NCT02721732 | Phase 2 | | 42 | Stem Cell Therapy Combined With NeuroRegen Scaffold™ in Patients With Erectile Dysfunction After Rectal Cancer Surgery | Recruiting | NCT02648386 | Phase 1, Phase 2 | | 43 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | Recruiting | NCT02834013 | Phase 2 | | 44 | A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP) | Active, not recruiting | NCT02057913 | Phase 2 | | 45 | Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis | Active, not recruiting | NCT02817958 | Phase 2 | | 46 | Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males | Active, not recruiting | NCT01209325 | Phase 2 | | 47 | Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types | Not yet recruiting | NCT03012581 | Phase 2 | | 48 | S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED) | Terminated | NCT00058448 | Phase 2 | | 49 | Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) | Terminated | NCT02279576 | Phase 2 | | 50 | Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE) | Withdrawn | NCT02014831 | Phase 2 |
Cochrane evidence based reviews: penile neoplasms
|
